6CM
REPL icon

683 Capital Management’s Replimune Group REPL Stock Holding History

683 Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,027
Closed -$93K – 239
2023
Q4 		$93K Buy
+11,027
New +$128K 0.01% 217

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

683 Capital Management's REPL Position: Q1 2024 in Review

683 Capital Management sold out of Replimune Group (REPL) in Q1 2024, closing a stake of 11,027 shares — an estimated $93K sold.

683 Capital Management first reported a position in REPL in Q4 2023 and held it in 1 quarter. The position peaked at $93K in Q4 2023. 150 funds tracked by Wall St. Rank hold REPL as of Q1 2024.

  • 683 Capital Management reported no remaining Replimune Group position as of Q1 2024 after selling out during the quarter.
  • 683 Capital Management sold 11,027 Replimune Group shares in Q1 2024, an estimated $93K.
  • 683 Capital Management first reported a position in Replimune Group in Q4 2023 and held it in 1 quarter.
  • 683 Capital Management's Replimune Group position peaked at $93K in Q4 2023.
  • 150 funds tracked by Wall St. Rank held Replimune Group as of Q1 2024.

Based on 683 Capital Management's 13F filing for Q1 2024, filed 15 May 2024.